Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.
Publication/Presentation Date
1-1-2022
Volume
126
Issue
1
First Page
162
Last Page
162
ISSN
1532-1827
Published In/Presented At
Quintanilha, J. C. F., Wang, J., Sibley, A. B., Jiang, C., Etheridge, A. S., Shen, F., Jiang, G., Mulkey, F., Patel, J. N., Hertz, D. L., Dees, E. C., McLeod, H. L., Bertagnolli, M., Rugo, H., Kindler, H. L., Kelly, W. K., Ratain, M. J., Kroetz, D. L., Owzar, K., Schneider, B. P., … Innocenti, F. (2022). Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients. British journal of cancer, 126(1), 162. https://doi.org/10.1038/s41416-021-01617-1
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
34853435
Department(s)
Administration and Leadership
Document Type
Article
COinS